| 2026-03-26 | Mr. Jonathan T. MolotCo-Founder & Chief Investment Officer | -1,10k | 8,50k | Sale to Issuer | 7,70 | 9,61M | -0,01% |
| 2026-03-26 | Mr. Christopher Peter BogartCo-Founder, CEO & Director | -1,10k | 8,50k | Sale to Issuer | 7,70 | 9,10M | -0,01% |
| 2026-03-26 | Ms. Elizabeth O’ConnellChief Strategy Officer | -13,03k | 100,32k | Derivative Exercise and Sale | 7,70 | 246,12k | - |
| 2026-03-26 | Ms. Elizabeth O’ConnellChief Strategy Officer | 19,61k | 0,00 | Derivative Exercise and Retained Stock | - | 246,12k | 8,66% |
| 2026-03-26 | Mr. Charles E. UtleyCAO | 12,54k | 0,00 | Derivative Exercise and Retained Stock | - | 31,40k | 66,49% |
| 2026-03-26 | Mr. Charles E. UtleyCAO | -8,47k | 65,19k | Derivative Exercise and Sale | 7,70 | 31,40k | - |
| 2026-03-26 | Mr. Jordan LichtCFO | -18,60k | 143,20k | Derivative Exercise and Sale | 7,70 | 68,35k | - |
| 2026-03-26 | Mr. Jordan LichtCFO | 17,83k | 0,00 | Derivative Exercise and Retained Stock | - | 68,35k | 35,29% |
| 2026-03-26 | Mr. David M. PerlaVice Chair & MD | -1,74k | 13,39k | Derivative Exercise and Sale | 7,70 | 81,12k | - |
| 2026-03-26 | Mr. David M. PerlaVice Chair & MD | 947,00 | 0,00 | Derivative Exercise and Retained Stock | - | 81,12k | 1,18% |
| 2026-03-26 | Mr. Craig Geoffrey ArnottChief Investment Officer of International | 36,43k | 0,00 | Derivative Exercise and Retained Stock | - | 303,43k | 13,64% |
| 2026-03-26 | Mr. Travis Dean LenknerCOO | 583,00 | 0,00 | Derivative Exercise and Retained Stock | - | 25,87k | 2,31% |
| 2026-03-26 | Mr. Travis Dean LenknerCOO | -517,00 | 3,98k | Derivative Exercise and Sale | 7,70 | 25,87k | - |
| 2026-03-26 | Mr. Mark N. KleinChief Administrative Officer & General Counsel | -18,15k | 139,74k | Derivative Exercise and Sale | 7,70 | 95,48k | - |
| 2026-03-26 | Mr. Mark N. KleinChief Administrative Officer & General Counsel | 18,28k | 0,00 | Derivative Exercise and Retained Stock | - | 95,48k | 23,68% |
| 2026-03-05 | Mr. Christopher Peter BogartCo-Founder, CEO & Director | 304,35k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 2,24M | 15,70% |
| 2026-03-05 | Mr. Jonathan T. MolotCo-Founder & Chief Investment Officer | 306,39k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 2,31M | 15,29% |
| 2026-03-05 | Mr. Jordan LichtCFO | 3,71k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 243,83k | 1,55% |
| 2026-03-05 | Mr. Travis Dean LenknerCOO | 81,69k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 255,35k | 47,04% |
| 2025-12-18 | Mr. Christopher A. HalmyIndependent Non-Executive Vice Chair | 5,08k | 46,99k | Acquisition Under Employee Benefit Plan | 9,26 | 42,25k | 13,65% |
| 2025-12-18 | Mr. Christopher A. HalmyIndependent Non-Executive Vice Chair | 5,08k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 8,02k | 172,50% |
| 2025-12-16 | Ms. Aviva O. WillInsider | 1,05k | 9,55k | Derivative Exercise and Retained Stock | 9,14 | 294,87k | 0,36% |
| 2025-12-16 | Ms. Aviva O. WillInsider | 349,00 | 0,00 | Acquisition Under Employee Benefit Plan | - | 294,87k | 0,12% |
| 2025-12-16 | Ms. Aviva O. WillInsider | 1,39k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 163,06k | 0,86% |
| 2025-12-05 | Mr. David M. PerlaVice Chair & MD | 9,71k | 90,17k | Derivative Exercise and Retained Stock | 9,29 | 89,88k | 12,11% |
| 2025-12-05 | Mr. David M. PerlaVice Chair & MD | 10,29k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 217,66k | 4,96% |
| 2025-12-01 | Mr. Jonathan T. MolotCo-Founder & Chief Investment Officer | 493,53k | 4,67M | Kauf | 9,46 | 9,47M | 5,50% |
| 2025-12-01 | Mr. Jonathan T. MolotCo-Founder & Chief Investment Officer | -493,53k | 4,67M | Verkauf | 9,46 | 9,47M | -4,95% |
| 2025-09-30 | Ms. Elizabeth O’ConnellChief Strategy Officer | -96,14k | 0,00 | Other Disposition | - | 34,75k | -73,45% |
| 2025-10-01 | Mr. Jordan LichtCFO | 50,52k | 0,00 | Derivative Exercise and Retained Stock | - | 50,52k | - |
| 2025-10-01 | Mr. Jordan LichtCFO | -52,69k | 638,08k | Derivative Exercise and Sale | 12,11 | 50,52k | - |
| 2025-08-21 | Mr. Christopher Peter BogartCo-Founder, CEO & Director | 66,90k | 909,89k | Derivative Exercise and Retained Stock | 13,60 | 9,51M | 0,71% |
| 2025-08-21 | Mr. Christopher Peter BogartCo-Founder, CEO & Director | 22,30k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-08-21 | Mr. Jonathan T. MolotCo-Founder & Chief Investment Officer | 65,28k | 887,77k | Derivative Exercise and Retained Stock | 13,60 | 9,47M | 0,69% |
| 2025-08-21 | Mr. Jonathan T. MolotCo-Founder & Chief Investment Officer | 2,74M | 37,44M | Kauf | 13,66 | 9,47M | 40,73% |
| 2025-08-21 | Mr. Jonathan T. MolotCo-Founder & Chief Investment Officer | -2,74M | 37,44M | Verkauf | 13,66 | 9,47M | -22,44% |
| 2025-08-21 | Mr. Jonathan T. MolotCo-Founder & Chief Investment Officer | 21,76k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-08-21 | Mr. Mark N. KleinChief Administrative Officer & General Counsel | 3,98k | 54,10k | Derivative Exercise and Retained Stock | 13,60 | 81,18k | 5,15% |
| 2025-08-21 | Mr. Mark N. KleinChief Administrative Officer & General Counsel | 1,33k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-08-21 | Mr. Jordan LichtCFO | 1,30k | 17,73k | Derivative Exercise and Retained Stock | 13,60 | 82,61k | 1,60% |
| 2025-08-21 | Mr. Jordan LichtCFO | 435,00 | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-08-21 | Mr. Jordan LichtCFO | 1,74k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 187,04k | 0,94% |
| 2025-08-21 | Mr. Mark N. KleinChief Administrative Officer & General Counsel | 5,30k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 94,45k | 5,95% |
| 2025-08-21 | Mr. Christopher Peter BogartCo-Founder, CEO & Director | 89,21k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,91M | 4,89% |
| 2025-08-21 | Mr. Jonathan T. MolotCo-Founder & Chief Investment Officer | -21,03k | 0,00 | Other Disposition | - | 9,41M | -0,22% |
| 2025-08-21 | Mr. Jonathan T. MolotCo-Founder & Chief Investment Officer | 87,04k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,98M | 4,60% |
| 2025-07-09 | Mr. Christopher Peter BogartCo-Founder, CEO & Director | -210,00k | 3,06M | Verkauf | 14,60 | 8,82M | -2,33% |
| 2025-07-09 | Mr. Jonathan T. MolotCo-Founder & Chief Investment Officer | -210,00k | 3,06M | Automatic Disposition | 14,60 | 9,41M | -2,18% |
| 2025-07-09 | Ms. Aviva O. WillInsider | -17,50k | 255,41k | Automatic Disposition | 14,60 | 293,48k | -5,63% |
| 2025-07-09 | Mr. David M. PerlaVice Chair & MD | -7,00k | 102,17k | Automatic Disposition | 14,60 | 80,17k | -8,03% |
| 2025-06-06 | Mr. Jonathan T. MolotCo-Founder & Chief Investment Officer | 39,43k | 0,00 | Derivative Exercise and Retained Stock | - | 9,62M | 0,41% |
| 2025-06-06 | Mr. Jonathan T. MolotCo-Founder & Chief Investment Officer | -15,31k | 196,82k | Derivative Exercise and Sale | 12,86 | 9,62M | - |
| 2025-06-06 | Mr. David M. PerlaVice Chair & MD | 4,68k | 0,00 | Derivative Exercise and Retained Stock | - | 87,17k | 5,68% |
| 2025-06-06 | Mr. David M. PerlaVice Chair & MD | -1,31k | 16,87k | Derivative Exercise and Sale | 12,86 | 87,17k | - |
| 2025-06-06 | Mr. Christopher Peter BogartCo-Founder, CEO & Director | 36,68k | 0,00 | Derivative Exercise and Retained Stock | - | 1,38M | 2,74% |
| 2025-06-06 | Mr. Christopher Peter BogartCo-Founder, CEO & Director | -13,33k | 171,39k | Derivative Exercise and Sale | 12,86 | 1,38M | - |
| 2025-06-06 | Mr. Christopher Peter BogartCo-Founder, CEO & Director | 36,68k | 471,67k | Derivative Exercise and Retained Stock | 12,86 | 9,44M | 0,39% |
| 2025-06-06 | Mr. David M. PerlaVice Chair & MD | 4,68k | 60,22k | Derivative Exercise and Retained Stock | 12,86 | 91,86k | 5,37% |
| 2025-06-06 | Mr. Jonathan T. MolotCo-Founder & Chief Investment Officer | 39,43k | 507,08k | Derivative Exercise and Retained Stock | 12,86 | 9,66M | 0,41% |